8-(dicyclopropylmethyl)-1,3-dipropylxanthine has been researched along with scopolamine hydrobromide in 1 studies
Studies (8-(dicyclopropylmethyl)-1,3-dipropylxanthine) | Trials (8-(dicyclopropylmethyl)-1,3-dipropylxanthine) | Recent Studies (post-2010) (8-(dicyclopropylmethyl)-1,3-dipropylxanthine) | Studies (scopolamine hydrobromide) | Trials (scopolamine hydrobromide) | Recent Studies (post-2010) (scopolamine hydrobromide) |
---|---|---|---|---|---|
14 | 0 | 0 | 7,548 | 563 | 1,401 |
Protein | Taxonomy | 8-(dicyclopropylmethyl)-1,3-dipropylxanthine (IC50) | scopolamine hydrobromide (IC50) |
---|---|---|---|
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.003 | |
Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.006 | |
Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.006 | |
Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.006 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.0006 | |
Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.006 | |
Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.006 | |
Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0026 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fuse, E; Ichikawa, S; Ishii, A; Kobayashi, H; Nakamura, J; Nonaka, H; Shimada, J; Shiozaki, S; Suzuki, F | 1 |
1 other study(ies) available for 8-(dicyclopropylmethyl)-1,3-dipropylxanthine and scopolamine hydrobromide
Article | Year |
---|---|
Adenosine A1 antagonists. 3. Structure-activity relationships on amelioration against scopolamine- or N6-((R)-phenylisopropyl)adenosine-induced cognitive disturbance.
Topics: Adenosine; Amnesia; Animals; Avoidance Learning; Diuretics; Male; Mice; Motor Activity; Phenylisopropyladenosine; Rats; Rats, Wistar; Receptors, Purinergic; Scopolamine; Structure-Activity Relationship; Xanthines | 1993 |